Evaluation of the cancer prevention efficacy of GLG-302
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $574,237
Award facts
- Opportunity
-
- N01CN201500036 Solicitation number
- Contract value 100% obligated
- $574,237.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3,055 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $577,292 |
About this award
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the University of Alabama at Birmingham (UAB) for the "Evaluation of the Cancer Prevention Efficacy of GLG-302." The $574,237 contract is part of the NCI's Preclinical Prevention Cancer Program, which focuses on preclinical efficacy and intermediate endpoint biomarkers for cancer prevention. The contract does not have a set-aside designation. UAB, a public research university and academic medical center, has extensive experience conducting biomedical research, including cancer studies, for federal agencies. The university has served as both a prime contractor and subcontractor on various federal projects, leveraging its diverse capabilities in areas like aerospace and engineering. This contract award builds on UAB's strong track record of securing federal funding to advance scientific knowledge and improve public health outcomes.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 24, 2015.
How much is contract HHSN26100003 worth?
The government has obligated $574,237 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201500036I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award